Valuation : Labcorp Holdings Inc.

Market Cap 26.04B 22.43B 21.17B 19.27B 36.02B 2,485B 36.39B 252B 96.89B 1,265B 97.78B 95.64B 4,022B P/E 2026 *
22x
P/E 2027 * 19.8x
Enterprise Value 31.19B 26.87B 25.36B 23.09B 43.15B 2,977B 43.59B 302B 116B 1,515B 117B 115B 4,817B EV / Sales 2026 *
2.11x
EV / Sales 2027 * 1.97x
Free-Float
99.65%
Yield 2026 *
0.95%
Yield 2027 * 0.96%

Last Transcript : Labcorp Holdings Inc.

1 day-4.40%
1 week-7.45%
Current month-7.73%
1 month-3.83%
3 months+13.17%
6 months+12.19%
Current year+22.35%
1 week 305.45
Extreme 305.45
330.56
1 month 305.45
Extreme 305.45
341.8
Current year 245
Extreme 245
341.8
1 year 244.52
Extreme 244.52
341.8
3 years 191.97
Extreme 191.97
341.8
5 years 191.97
Extreme 191.97
341.8
10 years 98.02
Extreme 98.02
341.8
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Free

Chief Technology Officer

3,000 0.0037%
01/09/26 Free

Chief Technology Officer

750 0.0009%
01/09/26 Free

EVP, COO

900 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
-4.40%-7.45%+10.37%+50.98% 26.04B
-1.26%+0.30%+84.92%+501.73% 47.61B
-0.67%+3.42%-14.67%-37.72% 6.95B
+4.81%-1.88%+1.64%+146.45% 5.58B
-0.16%+0.03%+20.70%+72.88% 3.37B
-2.91%-3.18%-33.35%+1,713.39% 2.58B
-0.28%+1.21%+124.05%+29.58% 2.27B
+12.21%+4.28%+33.33%+45.05% 2.17B
-2.03%-1.92%-19.22%-56.41% 1.81B
-0.01%+1.20%+38.19%+208.55% 1.62B
Average +0.53%+0.09%+24.60%+267.45% 10B
Weighted average by Cap. -1.38%+0.28%+45.85%+308.37%

Financials

2026 *2027 *
Net sales 14.75B 12.71B 11.99B 10.92B 20.4B 1,408B 20.61B 143B 54.88B 716B 55.38B 54.17B 2,278B 15.47B 13.33B 12.58B 11.45B 21.4B 1,477B 21.62B 150B 57.57B 751B 58.1B 56.83B 2,390B
Net income 1.13B 974M 919M 837M 1.56B 108B 1.58B 10.93B 4.21B 54.9B 4.24B 4.15B 175B 1.24B 1.07B 1.01B 919M 1.72B 119B 1.74B 12.01B 4.62B 60.32B 4.66B 4.56B 192B
Net Debt 5.15B 4.44B 4.19B 3.81B 7.12B 492B 7.2B 49.81B 19.16B 250B 19.34B 18.92B 795B 4.5B 3.88B 3.66B 3.33B 6.23B 430B 6.29B 43.54B 16.75B 219B 16.91B 16.54B 695B
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Employees
66,385
Date Price Change Volume
10/09/26 $306.96 -4.40% 1,257,806
09/09/26 $321.10 -1.16% 960,238
08/09/26 $324.86 -0.62% 615,723
04/09/26 $326.89 -1.39% 438,651
03/09/26 $331.50 -0.05% 520,645
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
321.10USD
Average target price
341.50USD
Spread / Average Target
+6.35%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!